Figure 2.

A representation of the highest HHV-8 seroprevalence observed in any one population in African countries (1998–2017). It should be borne in mind that the reported seroprevalences are from studied populations which employed different designs, approaches, populations, tests and interpretation algorithms, even within the same country. Thus, it could be difficult to make direct comparisons between and among studied populations [8,12,13,14,17,18,19,26,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98].